PL2435056T3 - Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych - Google Patents

Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych

Info

Publication number
PL2435056T3
PL2435056T3 PL10730508T PL10730508T PL2435056T3 PL 2435056 T3 PL2435056 T3 PL 2435056T3 PL 10730508 T PL10730508 T PL 10730508T PL 10730508 T PL10730508 T PL 10730508T PL 2435056 T3 PL2435056 T3 PL 2435056T3
Authority
PL
Poland
Prior art keywords
bacteriocin
food
pharmaceutical compositions
lactobacillus pentosus
producing lactobacillus
Prior art date
Application number
PL10730508T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PL2435056T3 publication Critical patent/PL2435056T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/167—Pentosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL10730508T 2009-05-27 2010-05-27 Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych PL2435056T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
EP10730508.8A EP2435056B1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
PCT/IB2010/001290 WO2010136891A1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PL2435056T3 true PL2435056T3 (pl) 2015-06-30

Family

ID=41434751

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10730508T PL2435056T3 (pl) 2009-05-27 2010-05-27 Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych

Country Status (11)

Country Link
US (1) US9185927B2 (pl)
EP (1) EP2435056B1 (pl)
JP (1) JP2012527884A (pl)
CN (1) CN102458426B (pl)
AU (1) AU2010252656B2 (pl)
BR (1) BRPI1011277B8 (pl)
ES (1) ES2534750T3 (pl)
IT (1) IT1397566B1 (pl)
PL (1) PL2435056T3 (pl)
RU (1) RU2547599C2 (pl)
WO (1) WO2010136891A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
JP2013150599A (ja) * 2011-12-27 2013-08-08 Nihon Univ 抗菌物質生産菌と発酵菌を共培養する発酵法
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
MY183171A (en) * 2013-04-17 2021-02-18 Suntory Holdings Ltd Composition containing bacterium belonging to genus lactobacillus
US20160115559A1 (en) * 2013-04-17 2016-04-28 Suntory Holdings Limited Bacterium belonging to genus lactobacillus
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130792A1 (it) * 2013-05-14 2014-11-15 Mofin S R L Metodo per la prevenzione e/o riduzione dello sviluppo della listeria nell'industria casearia e prevenzione della listeriosi nell'uomo.
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
LT6142B (lt) 2013-05-15 2015-04-27 Uab "Biocentras" Sėklinių grūdų ir sėklų apdorojimo būdas
TWI643626B (zh) * 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
CN106754506B (zh) * 2016-12-21 2020-12-29 四川东坡中国泡菜产业技术研究院 一种低盐泡菜微生态添加剂及其制备方法
CN111567619B (zh) * 2020-06-22 2023-04-14 扬州大学 一种高品质火麻发酵乳的制作方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product

Also Published As

Publication number Publication date
JP2012527884A (ja) 2012-11-12
BRPI1011277B8 (pt) 2021-05-25
ES2534750T3 (es) 2015-04-28
BRPI1011277A2 (pt) 2016-03-22
CN102458426A (zh) 2012-05-16
EP2435056B1 (en) 2015-01-28
US20120164119A1 (en) 2012-06-28
US9185927B2 (en) 2015-11-17
WO2010136891A1 (en) 2010-12-02
AU2010252656A1 (en) 2012-01-12
CN102458426B (zh) 2014-12-03
BRPI1011277B1 (pt) 2021-03-23
RU2011150659A (ru) 2013-07-10
ITRM20090270A1 (it) 2010-11-28
IT1397566B1 (it) 2013-01-16
EP2435056A1 (en) 2012-04-04
AU2010252656B2 (en) 2015-02-05
RU2547599C2 (ru) 2015-04-10

Similar Documents

Publication Publication Date Title
PL2435056T3 (pl) Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych
HK1173468A1 (en) Novel lactobacillus plantarum and composition comprising the same
EP2650002A4 (en) BIFIDOBACTERIUM CECT 7765 AND ITS USE IN PREVENTING AND / OR TREATING OVERWEIGHT, OBESITY AND ASSOCIATED PATHOLOGIES
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
HK1171474A1 (en) Novel lactobacillus plantarum and composition comprising same
IL218490A (en) Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations
EP2451300A4 (en) HEAT-RESISTANT PROBIOTIC COMPOSITIONS AND HEALTHY FOODS THEREFOR
PL2528610T3 (pl) Kompozycja probiotyczna do zastosowania w leczeniu zapalenia jelita
PL2476436T3 (pl) Peptydy immunogenne i ich zastosowanie w zaburzeniach immunologicznych
ZA201203941B (en) Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
PL2374835T3 (pl) Proszek poliamidowy 1010 i jego zastosowanie w produktach higieny osobistej
PL2474522T3 (pl) Agomelatyna i jej kompozycje farmaceutyczne
HK1182934A1 (zh) 種抗疲勞的組合物及其製劑和應用
EP2402429A4 (en) EQUOL-PRODUCING BACTERIUM AND ITS USE
EP2549891A4 (en) TEXTURAL AND TASTE AMPLIFIERS AND ITS USE IN FOOD MANUFACTURE
GB2453671B (en) Preparation for use in the treatment of Clostridium difficile and Salmonella
HK1187366A1 (zh) 新型細菌及所述細菌提取物、以及其在皮膚病中的用途
HK1174834A1 (en) Antiviral agent and food/beverage composition
EP2445895A4 (en) DITHIOCTATE OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
GB0914446D0 (en) Bioconjugates and their uses in imaging
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
PL2250179T3 (pl) Kompozycja na bazie lecytyny i jej zastosowanie w żywności
IL217137A0 (en) Medicinal and herbal composition and uses thereof
HUP0700029A2 (hu) Élelmiszer-kiegészítõ gyógyhatású készítmények és alkalmazásuk